GENOMIC STABILITY AND WILD-TYPE P53 FUNCTION OF LYMPHOBLASTOID-CELLS WITH GERM-LINE P53 MUTATION

被引:0
|
作者
LALLE, P
MOYRETLALLE, C
WANG, Q
VIALLE, JM
NAVARRO, C
BRESSACDEPAILLERETS, B
MAGAUD, JP
OZTURK, M
机构
[1] CTR LEON BERARD, INSERM, CJF 9302, ONCOL MOLEC LAB, F-69373 LYON 08, FRANCE
[2] HOP EDOUARD HERRIOT, INSERM, CJF 9307, CENT HEMATOL & CYTOGENET LAB, F-69437 LYON, FRANCE
[3] INST GUSTAVE ROUSSY, DIAGNOST MOLEC LAB, F-94805 VILLEJUIF, FRANCE
关键词
P53; LI-FRAUMENI SYNDROME; EPSTEIN-BARR VIRUS; LYMPHOBLASTOID CELLS; GENOMIC STABILITY;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased cancer risk associated with germ-line p53 mutation was linked to a deficit in the ability to maintain genomic stability. Accordingly, normal fibroblasts from cancer-prone individuals accumulate genomic aberrations with concomitant loss of mild-type p53 allele during in vitro culture. We tested whether such changes also occur in EBV-immortalized lymphoblastoid cells. Both normal and p53 germ-line mutant lymphoblastoid cells maintained functional p53 and genomic stability during long term in vitro culture. These unexpected differences between fibroblastic and lymphoblastic cells suggest that phenotypic expression of p53 deficiency is cell type specific. This could contribute to selective tissular localization of tumours observed in patients with Li-Fraumeni syndrome despite the presence of a mutant p53 allele in all cells.
引用
收藏
页码:2447 / 2454
页数:8
相关论文
共 50 条
  • [41] p53 gene status predicts response of epithelial cells to wild-type p53.
    St John, LS
    Sauter, ER
    Herlyn, M
    Litwin, S
    Alder-Storthz, K
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 167 - 167
  • [42] REGULATION OF THE STRUCTURE AND FUNCTION OF WILD-TYPE AND MUTANT FORMS OF P53
    BARGONETTI, H
    CHEN, XB
    FARMER, G
    FRIEDLANDER, P
    JAYARAMAN, L
    MANFREDI, J
    MILLER, S
    WANG, Y
    PRIVES, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 207 - 207
  • [43] Stable expression of temperature-sensitive p53: A suitable model to study wild-type p53 function in pancreatic carcinoma cells
    Nuevemann, Dieter
    Christgen, Matthias
    Ungefroren, Hendrik
    Kalthoff, Holger
    ONCOLOGY REPORTS, 2006, 16 (03) : 575 - 579
  • [44] WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO
    FARMER, G
    BARGONETTI, J
    ZHU, H
    FRIEDMAN, P
    PRYWES, R
    PRIVES, C
    NATURE, 1992, 358 (6381) : 83 - 86
  • [45] Small Fragment Homologous Replacement (SFHR) Modification of Genomic HPRT Occurs in the Presence of Wild-Type p53 in Lymphoblastoid Cells
    Bedayat, Babak
    Abdolmohammadi, Alireza
    Maurisse, Rosalie
    Shwarz, Jennifer
    Cheung, Judi
    De Semir, David
    O'Neill, PatricK
    Nicklas, Janice A.
    Gruenert, Dieter C.
    MOLECULAR THERAPY, 2006, 13 : S126 - S126
  • [46] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263
  • [47] The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
    Cadwell, C
    Zambetti, GP
    GENE, 2001, 277 (1-2) : 15 - 30
  • [48] Loss of wild-type p53 promotes colon cancer metastasis that express gain-of-function mutant p53
    Nakayama, Mizuho
    Hong, Chang Pyo
    Oshima, Hiroko
    Sakai, Eri
    Kim, Seong-Jin
    Oshima, Masanobu
    CANCER SCIENCE, 2021, 112 : 265 - 265
  • [49] Targeting gene expression to tumor cells with loss of wild-type p53 function
    Zhu, JD
    Gao, BM
    Zhao, JQ
    Balmain, A
    CANCER GENE THERAPY, 2000, 7 (01) : 4 - 12
  • [50] Targeting gene expression to tumor cells with loss of wild-type p53 function
    Jingde Zhu
    Baomei Gao
    Jiangqin Zhao
    Allan Balmain
    Cancer Gene Therapy, 2000, 7 : 4 - 12